CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-18 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +2,973 | 2,973 | ||
| 2021-03-18 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +11,889 | 11,889 | ||
| 2021-02-02 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +1,301 | 1,301 | ||
| 2021-02-02 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +3,215 | 3,215 | ||
| 2021-02-02 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +12,859 | 12,859 | ||
| 2020-12-28 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +11,081 | 11,081 | ||
| 2020-12-28 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +1,122 | 1,122 | ||
| 2020-12-28 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +2,771 | 2,771 | ||
| 2020-08-12 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-08-12 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-08-12 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-08-12 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +17,281 | 17,281 | ||
| 2020-05-14 | NIGON RICHARD Director | Grant or award · Stock Option (right to buy) | +25,308 | 25,308 | ||
| 2020-05-14 | Dalvey David Director | Grant or award | +7,843 | 7,843 | ||
| 2020-05-14 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +12,654 | 12,654 | ||
| 2020-05-14 | Furcht Leo Director | Grant or award · Stock Option (right to buy) | +25,308 | 25,308 | ||
| 2020-05-14 | Buller Richard E Director | Grant or award | +7,843 | 7,843 | ||
| 2020-05-14 | Buller Richard E Director | Grant or award · Stock Option (right to buy) | +12,654 | 12,654 | ||
| 2019-12-03 | Buller Richard E Director | Grant or award · Stock Option (right to buy) | +4,555 | 4,555 | ||
| 2019-08-12 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 17 of 19 · 365 trades